Author

Elif Tokar Erdemic

UnitedHealth Group (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Aaron J. WilkiD· 1 shared Aimee BeckiD· 1 shared Arjun RustagiiD· 1 shared Brooke E. HowittiD· 1 shared Catherine A. BlishiD· 1 shared Chengkun WangiD· 1 shared Grace Peters-Schulze· 1 shared Henry C. CousinsiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aaron J. WilkORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsbioRxivPreprintJul 1, 2021

CRISPRa screening with real world evidence identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2

Chengkun Wang, Ravi K. Dinesh, Yuanhao Qu…·Le Cong

The paper uses CRISPRa screening and real-world data to identify KCNA6 as a neuronal entry factor for SARS-CoV-2 and shows dalfampridine can suppress viral entry.

7 citations

humanscRNA-seq

𝕏 PostBluesky